Content Library for Today's
Technology Leaders

Latest Content
Pharmaceutical
IQVIA
Pharma Intelligence UK Ltd

Safety & Regulatory Compliance Predictions For 2025

Our panel of experts bring years of experience and deep insights into the evolving landscape of safety and regulatory compliance. Gain first-hand knowledge and specialized perspectives on the latest trends:
Webinar Clinical Studies Pharmaceutical Research and Development
ThermoFisher
Pharma Intelligence UK Ltd

Maximizing value across drug development: Embracing a new CDMO and CRO partnership approach

In this webinar, we will present key insights from preliminary findings by the TUFTS Center for the Study of Drug Development, exploring how a comprehensive model that brings CDMO and CRO services under one roof can significantly impact the expected Net Present Value (eNPV) of drug development programs. We will demonstrate how streamlined services across drug substance, drug product, and clinical research can enhance efficiency, reduce timelines, and ultimately deliver high-quality therapies to patients faster. Key takeaways include:
Webinar Clinical Studies Pharmaceutical Research and Development
SmartLabs
Pharma Intelligence UK Ltd

Getting The Most Out Of Your Lab Space

Join us for expert insights into:
Webinar Clinical Studies Pharmaceutical Research and Development
Novotech
Pharma Intelligence UK Ltd

Advances and opportunities in Liver Cancer research

Liver cancer is one of the leading causes of cancer death, with new cases predicted to rise by an alarming 70% by the time we reach 2025 (vs. 2022). Hepatocellular carcinoma, or HCC, accounts for 90% of cases, and poses significant challenges in treatment. Access this in-depth report to explore the global drug development landscape, and how promising advances in treatments are providing hope for the future. Explore topics including:
Report Clinical Studies Pharmaceutical Research and Development
Certara
Pharma Intelligence UK Ltd

Clinical Pharmacology & Model-Informed Drug Development Insights for Targeted Radiation Therapies (TRT)

Don’t miss insights from a recent recorded panel discussion among the subject matter area experts at Certara. Watch on demand to:
On-Demand Webinar Clinical Studies Pharmaceutical Research and Development
eClinical
Pharma Intelligence UK Ltd

Holistic Clinical Data Transformation: Setting the Stage for AI-Driven Productivity

Read now for expert insights into:
Report Clinical Studies Pharmaceutical Research and Development
Polpharma API

Why particles' size is important in pharmaceutical industry? Is it really problematic?

The whitepaper discusses the critical role of particle size distribution in pharmaceutical manufacturing, particularly for HPAPIs, and outlines methods for achieving desired particle sizes.
Whitepaper Pharmaceutical
Icon
Pharma Intelligence UK Ltd

Oncology roundtable report: how tech is transforming the landscape

Expert panellists address the key trends and challenges shaping the future of oncology, as they explore:
Report Clinical Studies Pharmaceutical Research and Development
Bachem
Pharma Intelligence UK Ltd

Mitigating Supply Chain Risk In An Age Of Disruption

Don’t miss expert insights on:
On-Demand Webinar Clinical Studies Pharmaceutical Research and Development

How It Works

RavenConnects is a free-to-access digital library and content subscription service designed for professional use with a wide-ranging library of whitepapers, e-books, case studies, guides, and articles.

You can make use of our search function and topic filtering to find relevant content quickly and easily. Our preference center puts you in control of your contact and content preferences for RavenConnects and our sister publications.

All our content is free to access and share, in exchange, we ask that we have your permission to disclose your professional details with the authors or content providers. At the bottom of this page you can find links to our jargon-free information on how we operate, and the data we process.

We will occasionally send you emails sharing content we believe is relevant to your role and company. You can control how we communicate with you using the Update Your Preferences link.